A former board member of Our Bodies, Ourselves, a nonprofit women’s advocacy group, publicly questioned why industry-funded studies were the only ones that appeared to show no higher risk of blood clots from the Yasmin line of contraceptives, compared to other types of birth control pills on the market.
An entry in the organization’s blog mentions testimony that Pamela Bridgewater presented at a U.S. Food and Drug Administration panel’s December ...
continue reading...
Researchers at the University of Michigan Health System are publishing a study this month in the Journal of Circulation indicating that older adults who get infections are nearly three times as likely to be hospitalized for a blood clot in their deep veins or lungs.
The study shows that recent exposure to an infection of any kind — including urinary, skin, or respiratory tract infections – is the most common ...
continue reading...A recent opinion piece in the New York Times calls for more public access to the clinical data that government agencies such as the U.S. Food and Drug Administration use for making policy about medications.
Authors Peter Doshi and Tom Jefferson write that drug or medical device manufacturers are required only to share their data with regulators, who treat the data as secret, and not with independent researchers or academics.
That ...
continue reading...
Officials with pharmaceutical giant Bayer said in a U.S. Securities and Exchange Commission filing that they expect more lawsuits over the company’s Yasmin line of birth control pills, Bloomberg reports. More than 11,000 lawsuits have already been filed over injuries allegedly caused by the drugs.
Last week, the company announced a settlement for about 500 lawsuits related to the contraceptives, which were the first batch of suits scheduled to go ...
continue reading...Bayer could end up paying billions of dollars settling lawsuits alleging that the German corporation’s Yasmin line of birth control pills caused blood clots.
In a settlement involving 500 lawsuits, news reports are claiming that the company is paying at least $110 million – amounting to about $220,000 a case.
In light of the fact that about 11,000 more lawsuits have been filed over injuries allegedly caused by the pills, the ...
continue reading...Bayer will pay at least $110 million, or an average of about $220,000 a case, to settle about 500 lawsuits over claims that its birth control pills caused blood clots, Bloomberg reports.
The lawsuits dealt with the company’s pills containing the compound drospirenone, which include Yasmin, Yaz, Ocella and Beyaz.
According to the Bloomberg report, the settlements came after a federal judge ...
continue reading...
